A multisite clinical trial of spectroscopic MRI-guided radiation dose escalation for newly-diagnosed glioblastomas.

Hui-Kuo George Shu,Eric A. Mellon,Lawrence Kleinberg,Saumya S. Gurbani,Karthik Ramesh,Mohammed Goryawala,Sulaiman Sheriff,Vicki Huang,Peter B. Barker,Andrew A. Maudsley,Eduard Schreibmann,Brent D. Weinberg,Hyunsuk Shim

A multisite clinical trial of spectroscopic MRI-guided radiation dose escalation for newly-diagnosed glioblastomas.

2021

Hui-Kuo George Shu
Eric A. Mellon
Lawrence Kleinberg
Saumya S. Gurbani
Karthik Ramesh
Mohammed Goryawala
Sulaiman Sheriff
Vicki Huang
Peter B. Barker
Andrew A. Maudsley
Eduard Schreibmann
Brent D. Weinberg
Hyunsuk Shim

2018Background: Glioblastoma (GBM) is the most common adult primary malignant brain tumor. These pts have poor outcomes [median overall survival (OS) 16 months] despite radiation therapy (RT) to ...

Keywords:

Glioblastoma
Radiology
overall survival
Medicine
Malignant brain tumor
Radiation therapy
mri guided
newly diagnosed
radiation dose
Clinical trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations